Barbara Bowers, MD
Ophthalmology · Paducah, KYNPI 1578530192
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,336 of the $9,236 with a category attached, or 79.4%. 28 manufacturers reported payments, led by Alcon at 30.4% of the total. Reporting peaked in 2022 at $2,912 and has fallen 68.4% since, to $920 in 2025. Among ophthalmology clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 253 payments — averaging $36.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$3K
- Amgen$2K
- Mallinckrodt Hospital Products Inc.$681
- Bausch & Lomb Americas Inc.$567
- AbbVie$381
- Glaukos Corporation$359
- plus $3K from 22 others
What the payments were for
- Speaking & faculty fees$1,50016%
- Food & beverage$7,33679%
- Education$1962%
- Gifts$641%
- Other$1402%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 71 | $2,811 |
| Amgen(2 entities) | 10 | $1,865 |
| Mallinckrodt Hospital Products Inc. | 17 | $681 |
| Bausch & Lomb Americas Inc. | 31 | $567 |
| AbbVie(2 entities) | 25 | $381 |
| Glaukos Corporation | 9 | $359 |
| Johnson & Johnson Surgical Vision, Inc. | 15 | $337 |
| Sun Pharmaceutical Industries Inc. | 10 | $326 |
| Biotissue Holdings Inc. | 5 | $194 |
| Novartis | 11 | $187 |
| Sight Sciences, Inc. | 4 | $162 |
| Ocular Therapeutix, Inc. | 3 | $160 |
| Shire North American Group Inc | 4 | $160 |
| Oyster Point Pharma, Inc. | 9 | $157 |
| Genentech USA, Inc. | 1 | $145 |
| Iridex Corporation | 1 | $127 |
| NEW World Medical,inc. | 1 | $111 |
| Apellis Pharmaceuticals, Inc. | 4 | $84 |
| Regeneron Healthcare Solutions, Inc. | 3 | $75 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $74 |
| Aerie Pharmaceuticals, Inc. | 4 | $56 |
| Carl Zeiss Meditec USA, Inc. | 2 | $53 |
| Dompe US, Inc. | 2 | $45 |
| Alcon Research LLC | 2 | $43 |
| Eyepoint US, Inc. | 2 | $32 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Beaver-visitec International, Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$1,604
- Hydrus Microstent$286
- XIIDRA$227
- VABYSMO$145
- ReSTOR$132
- PanOptix$114
- AcrySof IQ PanOptix$113
- Ahmed Glaucoma Valve$111
- Kahook Dual Blade$111
- OMNI(R) SURGICAL SYSTEM (US)$110
- ARGOS$108
- iStent Trabecular Micro-Bypass Stent System$107
- iStent inject Trabecular Micro-Bypass Stent System$107
- Photrexa$107
- MIEBO$102
How this compares
$9,236 in reported general payments places this provider in the 90th percentile of 216 ophthalmology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 106 | $5,822 |
| Ketorolac Tromethamine | 111 | $2,278 |
| MoxifloxacinMoxifloxacin Hcl | 70 | $1,883 |
| ValacyclovirValacyclovir Hcl | 51 | $1,749 |
| Ofloxacin | 26 | $412 |
| Tobramycin | 17 | $80 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Paducah
- Jeffery TaylorPaducah$18K
- Brian BodnarchukPaducah$6K
- Landen MeeksPaducah$6K
- Edward HollandEdgewood$678K
- Gary WortzLexington$159K
- Jeremy ClarkLouisville$131K
- Bruce KofflerLexington$49K
- Guruprasad PattarLouisville$36K
- Asim PirachaLexington$17K
- Gary FoulksLouisville$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.